keyword
https://read.qxmd.com/read/38710079/in-community-acquired-pneumonia-adding-oral-clarithromycin-to-standard-care-increased-early-clinical-response
#61
JOURNAL ARTICLE
Henry S Sacks
Giamarellos-Bourboulis EJ, Siampanos A, Bolanou A, et al. Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2024;12:294-304. 38184008.
May 7, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38710029/taurolidine-and-heparin-as-catheter-lock-solution-for-central-venous-catheters-in-hemodialysis
#62
JOURNAL ARTICLE
Timothy Nguyen, Bernard C Camins, David A Butler
BACKGROUND: Chronic kidney disease can lead to end-stage renal disease, and the prevalence is increasing. Many patients starting hemodialysis require central venous catheters (CVCs). Catheter-related bloodstream infections (CRBSIs) are a common complication and lead to significant morbidity and mortality. Interventions to prevent CRBSI include antimicrobial lock therapy but concern for the development of antimicrobial resistance and adverse effects. Nonantimicrobial antiseptics as catheter lock solutions have also been used...
May 7, 2024: American Journal of Therapeutics
https://read.qxmd.com/read/38709649/neuromuscular-electrical-stimulation-of-peroneal-longus-on-balance-control-ability-in-young-adults-with-chronic-ankle-instability-a-randomized-controlled-trial
#63
JOURNAL ARTICLE
Yueping Wang, Huifen Zheng, Jiangna Wang, Peiming Xu, Wei Sun
OBJECTIVE: This study aimed to investigate the effects of six weeks of peroneal longus neuromuscular electrical stimulation (NMES) on the balance control ability in young adults with chronic ankle instability (CAI). DESIGN: This study is a double blind randomized controlled trial. Six weeks of NMES and placebo intervention were conducted in the NMES and control groups for 20 minutes, three times a week, respectively. Thirty-eight participants successfully completed the whole intervention and single-leg standing tests...
April 30, 2024: American Journal of Physical Medicine & Rehabilitation
https://read.qxmd.com/read/38709502/ghrelin-for-neuroprotection-in-post-cardiac-arrest-coma-a-randomized-clinical-trial
#64
JOURNAL ARTICLE
Sjoukje Nutma, Albertus Beishuizen, Walter M van den Bergh, Norbert A Foudraine, Joost le Feber, P Margreet G Filius, Alexander D Cornet, Job van der Palen, Michel J A M van Putten, Jeannette Hofmeijer
IMPORTANCE: Out-of-hospital cardiac arrest survival rates have markedly risen in the last decades, but neurological outcome only improved marginally. Despite research on more than 20 neuroprotective strategies involving patients in comas after cardiac arrest, none have demonstrated unequivocal evidence of efficacy; however, treatment with acyl-ghrelin has shown improved functional and histological brain recovery in experimental models of cardiac arrest and was safe in a wide variety of human study populations...
May 6, 2024: JAMA Neurology
https://read.qxmd.com/read/38709500/cytisinicline-for-vaping-cessation-in-adults-using-nicotine-e-cigarettes-the-orca-v1-randomized-clinical-trial
#65
JOURNAL ARTICLE
Nancy A Rigotti, Neal L Benowitz, Judith J Prochaska, Daniel F Cain, Julie Ball, Anthony Clarke, Brent A Blumenstein, Cindy Jacobs
IMPORTANCE: The prevalence of e-cigarette use among US adults, especially young adults, is rising. Many would like to quit vaping nicotine but are unable to do so. Cytisinicline, a plant-based alkaloid, targets nicotinic acetylcholine receptors, reduces nicotine dependence, and helps adults to stop smoking cigarettes. Cytisinicline may also help e-cigarette users to quit vaping. OBJECTIVE: To determine the efficacy and safety of cytisinicline vs placebo to produce abstinence from e-cigarette use in adults seeking to quit vaping nicotine...
May 6, 2024: JAMA Internal Medicine
https://read.qxmd.com/read/38708959/the-effect-of-non-pooled-multi-donor-faecal-microbiota-transplantation-for-inducing-clinical-remission-in-patients-with-chronic-pouchitis-results-from-a-multicentre-randomised-double-blinded-placebo-controlled-trial-micropouch
#66
JOURNAL ARTICLE
Sabrina Just Kousgaard, Frederik Cold, Sofie Ingdam Halkjær, Andreas Munk Petersen, Jens Kjeldsen, Jane Møller Hansen, Sebastian Mølvang Dall, Mads Albertsen, Hans Linde Nielsen, Karina Frahm Kirk, Kirsten Duch, Mads Sønderkær, Ole Thorlacius-Ussing
BACKGROUND AND AIMS: To investigate if treatment with non-pooled multi-donor faecal microbiota transplantation (FMT) for four weeks was superior to placebo to induce clinical remission in patients with chronic pouchitis. METHODS: The study was a randomised double-blinded placebo-controlled study with a 4-week intervention period and 12-month follow-up. Eligible patients with chronic pouchitis were recruited from five Danish hospitals. Participants were randomised to non-pooled multi-donor FMT derived from four faecal donors, or placebo...
May 6, 2024: Journal of Crohn's & Colitis
https://read.qxmd.com/read/38708610/tramadol-paracetamol-for-postoperative-pain-after-spine-surgery-a-randomized-double-blind-placebo-controlled-study
#67
RANDOMIZED CONTROLLED TRIAL
Emma Lappalainen, Jukka Huttunen, Hannu Kokki, Petri Toroi, Merja Kokki
OBJECTIVES: Multimodal pain management is one component in enhanced recovery after surgery protocol. Here we evaluate the efficacy of tramadol-paracetamol in acute postoperative pain and pain outcome at 12 months after spine surgery in randomized, double-blind, placebo-controlled trial. METHODS: We randomized 120 patients undergoing spine surgery to receive, for add-on pain management, two tramadol-paracetamol 37.5 mg/325 mg ( n = 61) or placebo tablets ( n = 59) twice a day for 5 postoperative days...
January 1, 2024: Scandinavian Journal of Pain
https://read.qxmd.com/read/38708586/adult-and-pediatric-relapsing-multiple-sclerosis-phase-ii-and-phase-iii-trial-design-and-their-primary-end-points-a%C3%A2-systematic-review
#68
REVIEW
Katsutoshi Hiramatsu, Hideki Maeda
No systematic review of trial designs in patients with relapsing multiple sclerosis (RMS) was reported. This systematic review was conducted on the trial designs and primary end points (PEs) of phase II and III trials intended to modify the natural course of the disease in patients with RMS. The purpose of the study is to explore trends/topics and discussion points in clinical trial design and PE, comparing them to regulatory guidelines and expert recommendations. Three trial registration systems, ClinicalTrials...
May 2024: Clinical and Translational Science
https://read.qxmd.com/read/38707807/rationale-and-design-of-a-phase-2-double-blind-placebo-controlled-randomized-trial-evaluating-amp-kinase-activation-by-metformin-in-focal-segmental-glomerulosclerosis
#69
JOURNAL ARTICLE
Gabriel C Barsotti, Randy Luciano, Ashwani Kumar, Kristin Meliambro, Vijayakumar Kakade, Joji Tokita, Abhijit Naik, Jia Fu, Elizabeth Peck, John Pell, Anand Reghuvaran, E M Tanvir, Prashant Patel, Weijia Zhang, Fan Li, Gilbert Moeckel, Sudhir Perincheri, Lloyd Cantley, Dennis G Moledina, F Perry Wilson, John C He, Madhav C Menon
INTRODUCTION: Focal segmental glomerulosclerosis (FSGS), the most common primary glomerular disease leading to end-stage kidney disease (ESKD), is characterized by podocyte injury and depletion, whereas minimal change disease (MCD) has better outcomes despite podocyte injury. Identifying mechanisms capable of preventing podocytopenia during injury could transform FSGS to an "MCD-like" state. Preclinical data have reported conversion of an MCD-like injury to one with podocytopenia and FSGS by inhibition of AMP-kinase (AMPK) in podocytes...
May 2024: KI Reports
https://read.qxmd.com/read/38707756/evaluating-the-efficacy-of-methocarbamol-and-nefopam-in-orthopedic-surgical-pain
#70
JOURNAL ARTICLE
Ahmed N Al-Nasrawi, Mustafa W Al-Ibrahim, Saifali J Aljabran
Introduction Pain after orthopedic surgeries represents a special concern in patients with fractures. The use of multimodal analgesia significantly reduced the opioid need and reduced the risk of their side effects. Objectives This study compared the effectiveness and safety of methocarbamol and nefopam in the reduction of post-operative pain for patients undergoing orthopedic surgeries. Method This prospective, double-blind, randomized controlled trial took place at Al-Sader Teaching Hospital in Basrah, Iraq, from the first of February 2022 to the end of October 2023...
May 2024: Curēus
https://read.qxmd.com/read/38706951/effects-of-probiotic-supplementation-on-12%C3%A2-min-run-performance-mood-management-body-composition-and-gut-microbiota-in-amateur-marathon-runners-a-double-blind-controlled-trial
#71
JOURNAL ARTICLE
Le Wang, Fan-Jing Meng, Yi-Han Jin, Li-Qiang Wu, Ruo-Yu Tang, Kuang-Hui Xu, Yun Guo, Jun-Jie Mao, Jian-Ping Ding, Jie Li
BACKGROUND: Probiotic supplementation has a positive effect on endurance exercise performance and body composition in athletes, but the underlying mechanisms remain unclear. Gut microbiota can provide measurable markers of immune function in athletes, and microbial composition analysis may be sensitive enough to detect stress and metabolic disorders caused by exercise. METHODS: Nineteen healthy active amateur marathon runners (15 male and 4 female) with a mean age of 29...
October 2024: Journal of Exercise Science and Fitness
https://read.qxmd.com/read/38706390/efficacy-of-ferric-carboxymaltose-on-haemoglobin-response-among-older-patients-with-gastrointestinal-bleeding-a-randomised-clinical-trial
#72
RANDOMIZED CONTROLLED TRIAL
Nicolas Richard, Nadia Arab-Hocine, Margot Vannier, Rachida Leblanc-Boubchir, Agnès Pelaquier, Arnaud Boruchowicz, Marietta Musikas, Morgane Amil, Mathurin Fumery, Stéphane Nahon, Ramuntcho Arotcarena, Eve Gelsi, Arnaud Maurin, Xavier Hébuterne, Guillaume Savoye
BACKGROUND: Acute gastrointestinal bleeding (AGIB) is common in older patients but the use of iron in this context remains understudied. AIMS: This study aimed to evaluate prospectively the efficacy of ferric carboxymaltose to treat anaemia in older patients after AGIB. METHODS: This randomised double-blinded placebo-controlled clinical trial was conducted in 10 French centres. Eligible patients were 65 years or more, had controlled upper or lower gastrointestinal bleeding and a haemoglobin level of 9-11 g/dl...
May 1, 2024: Age and Ageing
https://read.qxmd.com/read/38706384/comparative-effectiveness-of-baloxavir-marboxil-and-oseltamivir-treatment-in-reducing-household-transmission-of-influenza-a-post-hoc-analysis-of-the-blockstone-trial
#73
RANDOMIZED CONTROLLED TRIAL
Hideyuki Ikematsu, Takamichi Baba, Masaya M Saito, Masahiro Kinoshita, Shogo Miyazawa, Ayano Hata, Saki Nakano, Yoshitake Kitanishi, Frederick G Hayden
BACKGROUND: The transmission of influenza virus in households, especially by children, is a major route of infection. Prior studies suggest that timely antiviral treatment of ill cases may reduce infection in household contacts. The aim of the study was to compare the effects of oseltamivir (OTV) and baloxavir marboxil (BXM) treatment of index cases on the secondary attack rate (SAR) of influenza within household. METHODS: A post hoc analysis was done in BLOCKSTONE trial-a placebo-controlled, double-blinded post-exposure prophylaxis of BXM...
May 2024: Influenza and Other Respiratory Viruses
https://read.qxmd.com/read/38706338/topiramate-versus-naltrexone-for-alcohol-use-disorder-a-genotype-stratified-double-blind-randomized-controlled-trial
#74
RANDOMIZED CONTROLLED TRIAL
Kirsten C Morley, Henry R Kranzler, Natasha Luquin, Nazila Jamshidi, Claire Adams, Mark Montebello, Chris Tremonti, Gezelle Dali, Warren Logge, Andrew Baillie, Maree Teesson, Ronald Trent, Paul S Haber
OBJECTIVE: There have been no well-controlled and well-powered comparative trials of topiramate with other pharmacotherapies for alcohol use disorder (AUD), such as naltrexone. Moreover, the literature is mixed on the effects of two polymorphisms-rs2832407 (in GRIK1 ) and rs1799971 (in OPRM1 )-on response to topiramate and naltrexone, respectively. The authors sought to examine the comparative effectiveness of topiramate and naltrexone in improving outcomes in AUD and to examine the role of the rs2832407 and rs1799971 polymorphisms, respectively, on response to these medications...
May 1, 2024: American Journal of Psychiatry
https://read.qxmd.com/read/38705988/demonstrating-the-effectiveness-of-intra-articular-prolotherapy-combined-with-peri-articular-perineural-injection-in-knee-osteoarthritis-a-randomized-controlled-trial
#75
RANDOMIZED CONTROLLED TRIAL
Yiling Fu, Yukun Du, Jianyi Li, Yongming Xi, Wenbin Ji, Tieshan Li
BACKGROUND: This study aimed to compare the efficacy of intra-articular prolotherapy (IG) combined with peri-articular perineural injection (PG) in the management of knee osteoarthritis (KOA). METHODS: A total of 60 patients with the diagnosis of KOA were included in this double-blinded randomized controlled clinical trials. The inclusion criteria were as follow: (1) 48-80 years old; (2) the diagnose of KOA; (3) the grade 2 and 3 of the Kellgern-Lawrence grading scale; (4) the pain, crepitation, and knee joint stiffness continuing for 3 months at least...
May 5, 2024: Journal of Orthopaedic Surgery and Research
https://read.qxmd.com/read/38705350/virtual-reality-action-observation-and-motor-imagery-to-enhance-neuroplastic-capacity-in-the-human-motor-cortex-a-pilot-double-blind-randomized-cross-over-trial
#76
JOURNAL ARTICLE
Niamh Connelly, Ellana Welsby, Belinda Lange, Brenton Hordacre
Neuroplasticity is important for learning, development and recovery from injury. Therapies that can upregulate neuroplasticity are therefore of interest across a range of fields. We developed a novel virtual reality action observation and motor imagery (VR-AOMI) intervention and evaluated whether it could enhance the efficacy of mechanisms of neuroplasticity in the human motor cortex of healthy adults. A secondary question was to explore predictors of the change in neuroplasticity following VR-AOMI. A pre-registered, pilot randomized controlled cross-over trial was performed...
May 3, 2024: Neuroscience
https://read.qxmd.com/read/38705341/obicetrapib-on-top-of-maximally-tolerated-lipid-modifying-therapies-in-participants-with-or-at-high-risk-for-atherosclerotic-cardiovascular-disease-rationale-and-designs-of-broadway-and-brooklyn
#77
JOURNAL ARTICLE
Stephen J Nicholls, Adam J Nelson, Marc Ditmarsch, John J P Kastelein, Christie M Ballantyne, Kausik K Ray, Ann Marie Navar, Steven E Nissen, Anne C Golberg, Liam R Brunham, Danielle Curcio, Erin Wuerdeman, Annie Neild, Douglas Kling, Andrew Hsieh, Mary R Dicklin, Brian A Ference, Ulrich Laufs, Maciej Banach, Roxana Mehran, Alberico L Catapano, Michael H Davidson
Obicetrapib, a novel, selective cholesteryl ester transfer protein (CETP) inhibitor, reduces low-density lipoprotein cholesterol (LDL-C), LDL particles, apolipoprotein (Apo) B, and lipoprotein(a) [Lp(a)] and increases high-density lipoprotein cholesterol (HDL-C) when added to statins with or without ezetimibe. By substantially reducing LDL-C, obicetrapib has the potential to lower atherogenic lipoproteins in patients with atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH) whose LDL-C levels remain high despite treatment with available maximally tolerated lipid-modifying therapies, addressing an unmet medical need in a patient population at high risk for cardiovascular events...
May 3, 2024: American Heart Journal
https://read.qxmd.com/read/38705167/seralutinib-in-adults-with-pulmonary-arterial-hypertension-torrey-a-randomised-double-blind-placebo-controlled-phase-2-trial
#78
JOURNAL ARTICLE
Robert P Frantz, Vallerie V McLaughlin, Sandeep Sahay, Pilar Escribano Subías, Ronald L Zolty, Raymond L Benza, Richard N Channick, Kelly M Chin, Anna R Hemnes, Luke S Howard, Olivier Sitbon, Jean-Luc Vachiéry, Roham T Zamanian, Matt Cravets, Robert F Roscigno, David Mottola, Robin Osterhout, Jean-Marie Bruey, Erin Elman, Cindy-Ann Tompkins, Ed Parsley, Richard Aranda, Lawrence S Zisman, Hossein-Ardeschir Ghofrani
BACKGROUND: Morbidity and mortality in pulmonary arterial hypertension (PAH) remain high. Activation of platelet-derived growth factor receptor, colony stimulating factor 1 receptor, and mast or stem cell growth factor receptor kinases stimulates inflammatory, proliferative, and fibrotic pathways driving pulmonary vascular remodelling in PAH. Seralutinib, an inhaled kinase inhibitor, targets these pathways. We aimed to evaluate the efficacy and safety of seralutinib in patients with PAH receiving standard background therapy...
May 2, 2024: Lancet Respiratory Medicine
https://read.qxmd.com/read/38704251/immunogenicity-and-safety-of-a-recombinant-omicron-ba-4-5-delta-covid-19-vaccine-zf2202-a-in-chinese-adults
#79
JOURNAL ARTICLE
Hua Hu, Fangli Ma, Lihui Gong, Yaqin Wang, Maodi Xu, Hua Sun, Qianqian Hu, Ping Wang, Lu Han, Haitang Xie
BACKGROUND: The Recombinant Omicron BA.4/5-Delta COVID-19 Vaccine (ZF2202-A) is primarily designed for the Delta and Omicron BA.4/5 variants. Our objective was to assess the safety and immunogenicity of ZF2202-A in Chinese adults. METHODS: A total of 450 participants aged ≥ 18 years, who had completed primary or booster vaccination with a COVID-19 vaccine more than 6 months prior, were enrolled in this randomized, double-blind, active-controlled trial...
May 3, 2024: Vaccine
https://read.qxmd.com/read/38703228/long-term-effects-of-an-egg-protein-hydrolysate-on-cognitive-performance-and-brain-vascular-function-a-double-blind-randomized-controlled-trial-in-adults-with-elevated-subjective-cognitive-failures
#80
JOURNAL ARTICLE
Micah S Adams, Ronald P Mensink, Jogchum Plat, Peter J Joris
PURPOSE: Short-term intake of the egg-protein hydrolysate Newtricious (NWT)-03 improved executive function, but underlying mechanisms and long-term effects, including other cognitive domains, are unknown. METHODS: A 36-week randomized controlled trial involving 44 overweight/obese individuals experiencing elevated Subjective Cognitive Failures (SCF; aged 60-75 years) assessed the impact of daily consumption of 5.7 g of NWT-03 or placebo powders on cognitive performance (psychomotor speed, executive function, memory) and Cerebral Blood Flow (CBF), a marker of brain vascular function...
May 4, 2024: European Journal of Nutrition
keyword
keyword
166583
4
5
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.